Microarray Market Size To Hit US$ 8.15 Billion By 2030

The global microarray market size is expected to hit around USD 8.15 billion by 2030 and progressing a CAGR of 8.2% over the forecast period 2022 to 2030.

Microarray Market Size 2017 to 2030

The on microarray Market, which provides a business strategy, research & development activities, concise outline of the market valuation, valuable insights pertaining to market share, size, supply chain analysis, competitive landscape and regional proliferation of this industry.

Download Free Sample@ https://www.precedenceresearch.com/sample/1201

Scope of the Report

Report Highlights	Details
Market Size	US$ 8.15 billion by 2030
Growth Rate	CAGR of 8.2% from 2021 to 2030
Base Year	2020
Historic Data	2017 to 2020
Forecast Period	2021 to 2030
Segments Covered	Product, Type, Application, End User
Regional Scope	North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA)

A recent report provides crucial insights along with application based and forecast information in the Global Microarray Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this market. This study also provides a detailed overview of the opportunities along with the current trends observed in the Microarray market.

A quantitative analysis of the industry is compiled for a period of 10 years in order to assist players to grow in the market. Insights on specific revenue figures generated are also given in the report, along with projected revenue at the end of the forecast period.

Companies and Manufacturers Covered

The study covers key players operating in the market along with prime schemes and strategies implemented by each player to hold high positions in the industry. Such a tough vendor landscape provides a competitive outlook of the industry, consequently existing as a key insight. These insights were thoroughly analysed and prime business strategies and products that offer high revenue generation capacities were identified. Key players of the global Microarray market are included as given below:

Microarray Market Key Players

Illumina, Inc.
Agilent Technologies, Inc.
Thermo Fisher Scientific, Inc.
Merck & Co., Inc.
PerkinElmer, Inc.
Arrayit Corporation
Bio-Rad Laboratories
GE Healthcare
Molecular Devices, LLC
Affymetrix

Market Segments

By Product

Consumables
Software & Services
Instruments

By Type

DNA Microarrays
Protein Microarrays
Other Microarrays

By Application

Agriculture
Research Applications
Drug Discovery
Diseases Diagnostics
Other Applications

By End User

Research & Academic Institutes
Pharmaceutical & Biotechnology Companies
Diagnostic Laboratories
Other End Users
Others

By Geography

North America
- - U.S.
  - Canada
Europe
- - Germany
  - France
  - United Kingdom
  - Rest of Europe
Asia Pacific
- - China
  - Japan
  - India
  - Southeast Asia
  - Rest of Asia Pacific
Latin America
- - Brazil
  - Rest of Latin America
Middle East & Africa (MEA)
- - GCC
  - North Africa
  - South Africa
  - Rest of Middle East & Africa

Report Objectives

To define, describe, and forecast the global microarray market based on product, and region
To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)
To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market
To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2
To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies3
To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the microarray market

Table of Content

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. DataSources
2.3. Assumptions& Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Microarray Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope

Chapter 5. COVID 19 Impact on Microarray Market

5.1. Covid-19: Microarray Industry Impact
5.2. Microarray Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and Microarray Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Microarray Market Players to deal with Covid-19 Pandemic Scenario

Chapter 6. Microarray Market Dynamics Analysis and Trends

6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Growing incidence of cancer worldwide
6.1.1.2. Increasing expenditure on research and development in the healthcare sector
6.1.2. Market Restraints
6.1.2.1. Stringent Regulations
6.1.3. Market Opportunities
6.1.3.1. Growing awareness regarding personalized medicines
6.1.3.2. Increasing preference for DNA based microarrays

Chapter 7. Global Microarray Market: Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Microarray Market Revenue by Market Players (2016 -2019)
7.1.1.2. MicroarrayMarket Revenue Market Share by Market Players (2016 -2019)
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of End-users

Chapter 8. Global Microarray Market, By Product

8.1. Microarray Market, by Product, 2017-2030
8.1.1. Consumables
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Software & Services
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Instruments
8.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Microarray Market, By Type

9.1. Microarray Market, by Type, 2017-2030
9.1.1. DNA Microarrays
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Protein Microarrays
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Other Microarrays
9.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Microarray Market, By Application

10.1. Microarray Market, by Application, 2017-2030
10.1.1. Agriculture
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Research Applications
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Drug Discovery
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Diseases Diagnostics
10.1.4.1. Market Revenue and Forecast (2017-2030)
10.1.5. Other Applications
10.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Microarray Market, By End User

11.1. Microarray Market, by End User, 2017-2030
11.1.1. Research & Academic Institutes
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Pharmaceutical & Biotechnology Companies
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Diagnostic Laboratories
11.1.3.1. Market Revenue and Forecast (2017-2030)
11.1.4. Other End Users
11.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Microarray Market, Regional Estimates and Trend Forecast

12.1. North America
12.1.1. Market Revenue Forecast by Product(2017-2030)
12.1.2. Market Revenue Forecast by Type(2017-2030)
12.1.3. Market Revenue Forecast by Application (2017-2030)
12.1.4. Market Revenue Forecast by End User (2017-2030)
12.1.5. U.S
12.1.5.1. Market Revenue Forecast (2017-2030)
12.1.6. Canada
12.1.6.1. Market Revenue Forecast (2017-2030)
12.2. Europe
12.2.1. Market Revenue Forecast by Product (2017-2030)
12.2.2. Market Revenue Forecast by Type (2017-2030)
12.2.3. Market Revenue Forecast by Application (2017-2030)
12.2.4. Market Revenue Forecast by End User (2017-2030)
12.2.5. UK
12.2.5.1. Market Revenue Forecast (2017-2030)
12.2.6. Germany
12.2.6.1. Market Revenue Forecast (2017-2030)
12.2.7. France
12.2.7.1. Market Revenue Forecast (2017-2030)
12.2.8. Rest of EU
12.2.8.1. Market Revenue Forecast (2017-2030)
12.3. Asia Pacific (APAC)
12.3.1. Market Revenue Forecast by Product (2017-2030)
12.3.2. Market Revenue Forecast by Type (2017-2030)
12.3.3. Market Revenue Forecast by Application (2017-2030)
12.3.4. Market Revenue Forecast by End User (2017-2030)
12.3.5. China
12.3.5.1. Market Revenue Forecast (2017-2030)
12.3.6. India
12.3.6.1. Market Revenue Forecast (2017-2030)
12.3.7. Japan
12.3.7.1. Market Revenue Forecast (2017-2030)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue Forecast (2017-2030)
12.4. LATAM
12.4.1. Market Revenue Forecast by Product (2017-2030)
12.4.2. Market Revenue Forecast by Type (2017-2030)
12.4.3. Market Revenue Forecast by Application (2017-2030)
12.4.4. Market Revenue Forecast by End User (2017-2030)
12.4.5. Brazil
12.4.5.1. Market Revenue Forecast (2017-2030)
12.4.6. Rest of LATAM
12.4.6.1. Market Revenue Forecast (2017-2030)
12.5. Middle East and Africa (MEA)
12.5.1. Market Revenue Forecast by Product (2017-2030)
12.5.2. Market Revenue Forecast by Type (2017-2030)
12.5.3. Market Revenue Forecast by Application (2017-2030)
12.5.4. Market Revenue Forecast by End User (2017-2030)
12.5.5. GCC
12.5.5.1. Market Revenue Forecast (2017-2030)
12.5.6. North Africa
12.5.6.1. Market Revenue Forecast (2017-2030)
12.5.7. South Africa
12.5.7.1. Market Revenue Forecast (2017-2030)
12.5.8. Rest of MEA
12.5.8.1. Market Revenue Forecast (2017-2030)

Chapter 13. Company Profiles

13.1. Illumina, Inc.
13.1.1. Company Overview, Business Information, Regional Presence
13.1.2. Product Portfolio Analysis
13.1.2.1. Product Details, Specification, Application
13.1.3. Revenue, Price, and Gross Margin (2015-2020)
13.1.4. Recent Developments and Strategies
13.2. Agilent Technologies, Inc.
13.2.1. Company Overview, Business Information, Regional Presence
13.2.2. Product Portfolio Analysis
13.2.2.1. Product Details, Specification, Application
13.2.3. Revenue, Price, and Gross Margin (2015-2020)
13.2.4. Recent Developments and Strategies
13.3. Thermo Fisher Scientific, Inc.
13.3.1. Company Overview, Business Information, Regional Presence
13.3.2. Product Portfolio Analysis
13.3.2.1. Product Details, Specification, Application
13.3.3. Revenue, Price, and Gross Margin (2015-2020)
13.3.4. Recent Developments and Strategies
13.4. Merck & Co., Inc.
13.4.1. Company Overview, Business Information, Regional Presence
13.4.2. Product Portfolio Analysis
13.4.2.1. Product Details, Specification, Application
13.4.3. Revenue, Price, and Gross Margin (2015-2020)
13.4.4. Recent Developments and Strategies
13.5. PerkinElmer, Inc.
13.5.1. Company Overview, Business Information, Regional Presence
13.5.2. Product Portfolio Analysis
13.5.2.1. Product Details, Specification, Application
13.5.3. Revenue, Price, and Gross Margin (2015-2020)
13.5.4. Recent Developments and Strategies
13.6. Arrayit Corporation
13.6.1. Company Overview, Business Information, Regional Presence
13.6.2. Product Portfolio Analysis
13.6.2.1. Product Details, Specification, Application
13.6.3. Revenue, Price, and Gross Margin (2015-2020)
13.6.4. Recent Developments and Strategies
13.7. Bio-Rad Laboratories
13.7.1. Company Overview, Business Information, Regional Presence
13.7.2. Product Portfolio Analysis
13.7.2.1. Product Details, Specification, Application
13.7.3. Revenue, Price, and Gross Margin (2015-2020)
13.7.4. Recent Developments and Strategies
13.8. GE Healthcare
13.8.1. Company Overview, Business Information, Regional Presence
13.8.2. Product Portfolio Analysis
13.8.2.1. Product Details, Specification, Application
13.8.3. Revenue, Price, and Gross Margin (2015-2020)
13.8.4. Recent Developments and Strategies
13.9. Molecular Devices, LLC
13.9.1. Company Overview, Business Information, Regional Presence
13.9.2. Product Portfolio Analysis
13.9.2.1. Product Details, Specification, Application
13.9.3. Revenue, Price, and Gross Margin (2015-2020)
13.9.4. Recent Developments and Strategies
13.10. Affymetrix
13.10.1. Company Overview, Business Information, Regional Presence
13.10.2. Product Portfolio Analysis
13.10.2.1. Product Details, Specification, Application
13.10.3. Revenue, Price, and Gross Margin (2015-2020)
13.10.4. Recent Developments and Strategies